![]() Once in place, this IUD is effective contraception for seven years.Fibroids are mostly dependent on estrogen to stimulate their growth. An exception to this seems to be the progesterone-containing IUD, Mirena, which reduces menstrual flow, and in one recent study, has been shown to shrink fibroids slightly. In fact, birth control pills can sometimes make them grow. Hormonal treatments have relatively little effect on fibroids. ![]() Are there medical treatments for fibroids? In still other situations, the size and position of the fibroid(s) may cause pain during intercourse, increased menstrual cramps, or decreased bladder capacity. Others will cause heavy and prolonged periods. Very rarely, about 1 in 10,000 cases, a fibroid may develop into a sarcoma, or very aggressive cancer.Many fibroids produce no symptoms at all, and are simply noted during the course of routine annual examinations and Pap smears. Symptoms are caused by the size of the fibroids themselves (heaviness or pressure in the pelvis), or by pressure on surrounding organs such as the bladder or large intestine. Whether or not treatment is needed depends on the size, location, and rate of growth of the fibroids. Some fibroids will remain stable in size over many years while others will appear suddenly and grow quite rapidly. ![]() Both estrogen and progesterone hormones (products of the ovaries) are thought to promote the growth of fibroids. Each fibroid is thought to arise from a single cell which grows into a mass. All rights reserved.Fibroids are benign (non-cancerous) tumors, or growths, within the muscle wall of the uterus. If the difference is found, perhaps therapy can be targeted against this difference, and screening tests for advanced ovarian cancer can be improved.Ĭopyright © 2013 Elsevier Ltd. Basic science research comparing the tissue microarrays of early versus advanced stage disease may be able to identify this difference. Theoretically there may be a factor that separates these 2 into different diseases, where advanced disease patients have a substance produced by their tumor that allows for early dissemination, and early stage lacks this substance and only grows locally. Early stage grows locally and does not disseminate, and advanced stage disseminates while the tumor is still relatively small. This finding supports the fact that early versus advanced ovarian cancer are 2 separate disease processes. Overall, patients with early stage ovarian cancer have diseased ovaries that are more than twice as large as those found in advanced disease. This difference was statistically significant (p<0.001). The average measurement was 4.8 cm in advanced disease, and was 10.7 cm in early stage disease. There were 110 patients analyzed: 85 with advanced disease, 25 with early stage. The dimensions for each patient were averaged into a single dimension for that patient, and then these measurements were totaled and averaged. Patient stage and all available dimensions measured on diseased ovaries were recorded. Only cases with documentation of surgical and pathologic staging and measured dimensions on pathologic specimen were included. Patients had epithelial ovarian cancer, other cell types were excluded. ![]() This was a retrospective chart review of patients in the tumor registry in 2003-2006. Theoretically if this is so, then patients with advanced stage should have smaller sized tumors than patients with early stage. ![]() The mechanism of disease progression is unknown, but patients with advanced disease may have a higher propensity for seeding of the abdominal cavity early in the disease process than those with early stage. Ovarian cancer has a different prognosis between early (I and II) and advanced stage (III and IV). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |